BK Virus in Recipients of Kidney Transplants.
Since its discovery in 1971, the BK virus, a human polyomavirus, has emerged as a significant cause of renal dysfunction and transplant graft loss in kidney transplant recipients. Improved screening methods have been effective in assisting in the early identification of the virus, and thus, prompt i...
| Published in: | Nephrology Nursing Journal Vol. 41; no. 6; pp. 593 - 603 |
|---|---|
| Main Author: | |
| Format: | CEU exam questions forms tables/charts Journal Article |
| Published: |
American Nephrology Nurses' Association
Nov/Dec2014
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=99987564&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 99987564 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1526744X EC1 jtl: Nephrology Nursing Journal issn: 1526744X maglogo: N pubinfo: dt: Nov/Dec2014 vid: 41 iid: 6 pid: 6438 pub: American Nephrology Nurses' Association place: Pitman, New Jersey artinfo: ui: 99987564 99987564 103926781 99987564 ppf: 593 ppct: 10 formats: fmt: @attributes: type: P tig: atl: BK Virus in Recipients of Kidney Transplants. aug: au: Hendrix, Kelly M. affil: Transplant Nurse Coordinator, Multi-Organ Transplant Program, William Beaumont Hospital, Royal Oak, MI sug: subj: Kidney Transplantation Polyomavirus Infections Immunosuppressive Agents Administration and Dosage Graft Rejection Transplant Recipients Education, Continuing (Credit) Polyomavirus Infections Risk Factors Polyomavirus Infections Physiopathology Polyomavirus Infections Transmission Polyomavirus Infections Diagnosis Polyomavirus Infections Urine Polymerase Chain Reaction Polyomavirus Infections Prevention and Control Polyomavirus Infections Therapy Leflunomide Therapeutic Use Antiinfective Agents, Fluoroquinolone Therapeutic Use Immunoglobulins, Intravenous ab: Since its discovery in 1971, the BK virus, a human polyomavirus, has emerged as a significant cause of renal dysfunction and transplant graft loss in kidney transplant recipients. Improved screening methods have been effective in assisting in the early identification of the virus, and thus, prompt intervention to prevent the progression of the disease. Treatment options for the virus are limited; therefore, lowering immunosuppressive medications should be considered the first line of treatment. Current adjunctive therapies are not guaranteed to control the viral activity and may have limited therapeutic value. pubtype: Academic Journal doctype: CEU exam questions forms tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|